Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Maxillofacial Plastic and Reconstructive Surgery
Published in: Maxillofacial Plastic and Reconstructive Surgery 1/2019

Open Access 01-12-2019 | Bruxism | Review

Application of botulinum toxin in maxillofacial field: part I. Bruxism and square jaw

Authors: Kyung-Hwan Kwon, Kyung Su Shin, Sung Hee Yeon, Dae Gun Kwon

Published in: Maxillofacial Plastic and Reconstructive Surgery | Issue 1/2019

Login to get access

Abstract

The application of botulinum in oral and maxillofacial surgery begins in 1982, where Jan Carruthers started using it for reducing the muscle mass and smoothing the skin, and since then it has been used for cosmetic purposes. In Korea, it is already being used by various specialties including dentistry (oral and maxillofacial surgery, oral medicine), plastic surgery, dermatology, ophthalmology, general surgery, and orthopedic surgery, etc. Each specialty approaches to Botox with its own medical indications. In this article, we will discuss the maxillofacial application of botulinum toxin, which includes theoretical and practical aspects of such as bruxism and square jaw.
Literature
1.
Scott AB (1980) Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Ophthalmology 87:1044–1049CrossRef
2.
Selter PE (2002) Therapeutic use of botulinum toxins: Background and History. Clin J Pain 18:119–124CrossRef
3.
Simpson LL (2000) Identification of the characteristics that underlie botulinum toxin potency: implications for designing novel drugs. Biochemie 82:943–953CrossRef
4.
Freud B, Schwartz M, Symington J (1999) The use of botulinum toxin for the treatment of temporomandibular disorders: Preliminary findings. J Oral Maxillofac Surg 57:916–920CrossRef
5.
Lu DW, Lippitz J (2009) Complications of botulinum neurotoxin. Dis Mon. 55:198–211CrossRef
6.
Popoff MR, Bouvet P (2013) Genetic characteristics of toxigenic Clostridia and toxin gene evolution. Toxicon 75:63–89CrossRef
7.
Van Zndiijcke M, Marchau MM (1990) Treatment of bruxism with botulinum toxin injections. J Neurol Neurosurg Psychiatry 1990;53:530.
8.
Smyth AG (1994) Botulinum toxin treatment of bilateral masseteric hypertrophy. Br. J. Oral Maxillofacial Surg 32:29–33CrossRef
9.
10.
Archana MS (2016) Toxin yet not toxic: botulinum toxin in dentistry. Saudi Dent J 28:63–69CrossRef
11.
12.
Carruthers J, Carruthers A. (1991) Botulinum toxin use on Glabells wrinkles. Presented at the annual meeting of the American Society for dermatologic surgery Orlando florida. 13-17 March. 1991
13.
Carruthers JD, Carruthers JA (1992) Treatment of glabellar frown lines with C. botulinum-A exotoxin. J Dermatol Surg Oncol 18:17–21CrossRef
14.
To EW, Ahuja AT, Ho WS, King WW, Wong WK, Pang PC, Hui AC (2001) A prospective study of the effect of botulinum toxin A on masseteric muscle hypertrophy with ultrasonographic and electromyographic measurement. Br J Plat Surg 54:197–200CrossRef
15.
Sano K, Ninomiya H, Ckine J, Michael B, Pe MB, Inokuchi T (1991) Application of magnetic resonance imaging and ultrasonography to preoperative evaluation of masseteric hypertrophy. J Craniomaxillofac Surg 19:223–226CrossRef
16.
Loder E, Biondi D (2002) Use of botulinum toxins for chronic headaches: A focused review. The Clin J Pain 18:169–176CrossRef
17.
Pidcock FS, Wise JM, Christensen JR (2002) Treatment of severe post-traumatic bruxism with botulinum toxin-A: Case Report. J Oral Maxillofac Surg 60:115–117CrossRef
18.
Ivanhoe CB, Lai JM, Francisco GE (1997) Bruxism after brain injury: Successful treatment with Botulinum toxin-A. Arch Phys Med Rehabil 78:1272–1273CrossRef
19.
Freund B, Schwartz M, Symington JM (1999) The use of botulinum toxin for the treatment of temporomandibular disorders: preliminary findings. J Oral Maxillofac Surg 57:916–920CrossRef
20.
Niamtu J 3rd (2003) Botulinum toxin A: a review of 1,085 oral and maxillofacial patient treatments. J Oral Maxillofac Surg 61:317-324.CrossRef
21.
Attanasio R (1997) An overview of bruxism and its management. Dent Clin North Am 41:229–241PubMed
22.
Pratap-Chand R, Gourie-Devi M (1985) Bruxism: its significance in coma. Clin Neurol Neurosurg 87:113–117CrossRef
Metadata
Title
Application of botulinum toxin in maxillofacial field: part I. Bruxism and square jaw
Authors
Kyung-Hwan Kwon
Kyung Su Shin
Sung Hee Yeon
Dae Gun Kwon
Publication date
01-12-2019
Publisher
Springer Berlin Heidelberg
Published in
Maxillofacial Plastic and Reconstructive Surgery / Issue 1/2019
Electronic ISSN: 2288-8586
DOI
https://doi.org/10.1186/s40902-019-0218-0

Other articles of this Issue 1/2019

Maxillofacial Plastic and Reconstructive Surgery 1/2019 Go to the issue

Case report

Maxillary reconstruction using tunneling flap technique with 3D custom-made titanium mesh plate and particulate cancellous bone and marrow graft: a case report

Research

Pharmacoepidemiology and clinical characteristics of medication-related osteonecrosis of the jaw

Methodology

Floating septum technique: easy and safe method maxillary sinus septa in sinus lifting procedure

Research

Comparison of time and cost between conventional surgical planning and virtual surgical planning in orthognathic surgery in Korea

Case report

A case report of a long-term abandoned torn lingual nerve injury repaired by collagen nerve graft induced by lower third molar extraction

Review

Application of botulinum toxin in maxillofacial field: Part III. Ancillary treatment for maxillofacial surgery and summary